HRT Financial’s TherapeuticsMD TXMD Stock Holding History

HRT Financial’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32K	Buy	+14,727	New	+$30.4K	﹤0.01%	3863
2022 Q1	–	Sell	-15,104	Closed	-$268K	–	3882
2021 Q4	$268K	Sell	15,104 -431	-3%	-$12.9K	﹤0.01%	2340
2021 Q3	$575K	Buy	15,535 +4,313	+38%	+$191K	﹤0.01%	1857
2021 Q2	$667K	Buy	+11,222	New	+$680K	0.01%	1520
2020 Q3	–	Sell	-3,394	Closed	-$212K	–	2365
2020 Q2	$212K	Buy	+3,394	New	+$198K	0.01%	1134
2019 Q3	–	Sell	-1,030	Closed	-$133K	–	1606
2019 Q2	$133K	Buy	1,030 +807	+362%	+$145K	0.01%	657
2019 Q1	$54K	Buy	+223	New	+$59K	0.01%	461

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

HRT Financial's TXMD Position: Q2 2026 in Review

HRT Financial opened a new position in TherapeuticsMD (TXMD) in Q2 2026: 14,727 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #3863 among its holdings. This is a return to the name: HRT Financial previously reported a position in TXMD as recently as Q4 2021.

HRT Financial first reported a position in TXMD in Q1 2019 and has held it in 7 quarters since. The position peaked at $667K in Q2 2021. 44 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

HRT Financial held 14,727 shares of TherapeuticsMD worth $32K as of Q2 2026.
TherapeuticsMD was a new HRT Financial position in Q2 2026.
TherapeuticsMD made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3863 holding.
HRT Financial first reported a position in TherapeuticsMD in Q1 2019 and has held it in 7 quarters since.
HRT Financial's TherapeuticsMD position peaked at $667K in Q2 2021.
44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.